Influence of breast cancer risk factors and intramammary biotransformation on estrogen homeostasis in the human breast
Open Access
- 22 June 2020
- journal article
- research article
- Published by Springer Nature in Archives of Toxicology
- Vol. 94 (9) , 3013-3025
Abstract
Understanding intramammary estrogen homeostasis constitutes the basis of understanding the role of lifestyle factors in breast cancer etiology. Thus, the aim of the present study was to identify variables influencing levels of the estrogens present in normal breast glandular and adipose tissues (GLT and ADT, i.e., 17β-estradiol, estrone, estrone-3-sulfate, and 2-methoxy-estrone) by multiple linear regression models. Explanatory variables (exVARs) considered were (a) levels of metabolic precursors as well as levels of transcripts encoding proteins involved in estrogen (biotrans)formation, (b) data on breast cancer risk factors (i.e., body mass index, BMI, intake of estrogen-active drugs, and smoking) collected by questionnaire, and (c) tissue characteristics (i.e., mass percentage of oil, oil%, and lobule type of the GLT). Levels of estrogens in GLT and ADT were influenced by both extramammary production (menopausal status, intake of estrogen-active drugs, and BMI) thus showing that variables known to affect levels of circulating estrogens influence estrogen levels in breast tissues as well for the first time. Moreover, intratissue (biotrans)formation (by aromatase, hydroxysteroid-17beta-dehydrogenase 2, and beta-glucuronidase) influenced intratissue estrogen levels, as well. Distinct differences were observed between the exVARs exhibiting significant influence on (a) levels of specific estrogens and (b) the same dependent variables in GLT and ADT. Since oil% and lobule type of GLT influenced levels of some estrogens, these variables may be included in tissue characterization to prevent sample bias. In conclusion, evidence for the intracrine activity of the human breast supports biotransformation-based strategies for breast cancer prevention. The susceptibility of estrogen homeostasis to systemic and tissue-specific modulation renders both beneficial and adverse effects of further variables associated with lifestyle and the environment possible.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (LE 1329/10–1)
This publication has 49 references indexed in Scilit:
- Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidenceThe Lancet, 2019
- 17β-Estradiol up-regulates UDP-glucuronosyltransferase 1A9 expression via estrogen receptor αActa Pharmaceutica Sinica B, 2016
- The number of subjects per variable required in linear regression analysesJournal of Clinical Epidemiology, 2015
- The serum estradiol concentration is the main determinant of the estradiol concentration in normal breast tissueMaturitas, 2015
- Impact of Obesity on Mammary Gland Inflammation and Local Estrogen ProductionJournal of Mammary Gland Biology and Neoplasia, 2014
- Current strategies for the prevention of breast cancerBreast Cancer: Targets and Therapy, 2014
- Priorities for the primary prevention of breast cancerCA: A Cancer Journal for Clinicians, 2014
- Aromatase, breast cancer and obesity: a complex interactionTrends in Endocrinology & Metabolism, 2012
- Retinoic Acid (RA) Regulates 17β-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometrium: Interaction of RA Receptors with Specificity Protein (SP) 1/SP3 for Estradiol MetabolismThe Journal of Clinical Endocrinology & Metabolism, 2008
- Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective StudiesJNCI: Journal of the National Cancer Institute, 2002